The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

IVF-Procedure-Global Market Insights and Sales Trends 2024

IVF-Procedure-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1881308

No of Pages : 100

Synopsis
The global IVF-Procedure market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of IVF-Procedure in various end use industries. The expanding demands from the Fertility Clinics, Hospitals, Surgical Centers and Research Laboratories, are propelling IVF-Procedure market. Fresh Non-Donor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Frozen Non-Donor segment is estimated at % CAGR for the next seven-year period.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for IVF-Procedure, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global IVF-Procedure market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global IVF-Procedure market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, IVF-Procedure sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of IVF-Procedure covered in this report include OvaScience, EMD Serono, Vitrolife, Irvine Scientific, Cook Medical Inc, Cooper Surgical Inc, Genea Biomedx, Thermo Fisher Scientific and Progyny, etc.
The global IVF-Procedure market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
OvaScience
EMD Serono
Vitrolife
Irvine Scientific
Cook Medical Inc
Cooper Surgical Inc
Genea Biomedx
Thermo Fisher Scientific
Progyny
Boston IVF
Global IVF-Procedure market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global IVF-Procedure market, Segment by Type:
Fresh Non-Donor
Frozen Non-Donor
Fresh Donor
Frozen Donor
Global IVF-Procedure market, by Application
Fertility Clinics
Hospitals
Surgical Centers
Research Laboratories
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of IVF-Procedure companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of IVF-Procedure
1.1 IVF-Procedure Market Overview
1.1.1 IVF-Procedure Product Scope
1.1.2 IVF-Procedure Market Status and Outlook
1.2 Global IVF-Procedure Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global IVF-Procedure Market Size by Region (2018-2029)
1.4 Global IVF-Procedure Historic Market Size by Region (2018-2023)
1.5 Global IVF-Procedure Market Size Forecast by Region (2024-2029)
1.6 Key Regions, IVF-Procedure Market Size (2018-2029)
1.6.1 North America IVF-Procedure Market Size (2018-2029)
1.6.2 Europe IVF-Procedure Market Size (2018-2029)
1.6.3 Asia-Pacific IVF-Procedure Market Size (2018-2029)
1.6.4 Latin America IVF-Procedure Market Size (2018-2029)
1.6.5 Middle East & Africa IVF-Procedure Market Size (2018-2029)
2 IVF-Procedure Market by Type
2.1 Introduction
2.1.1 Fresh Non-Donor
2.1.2 Frozen Non-Donor
2.1.3 Fresh Donor
2.1.4 Frozen Donor
2.2 Global IVF-Procedure Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global IVF-Procedure Historic Market Size by Type (2018-2023)
2.2.2 Global IVF-Procedure Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America IVF-Procedure Revenue Breakdown by Type (2018-2029)
2.3.2 Europe IVF-Procedure Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific IVF-Procedure Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America IVF-Procedure Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa IVF-Procedure Revenue Breakdown by Type (2018-2029)
3 IVF-Procedure Market Overview by Application
3.1 Introduction
3.1.1 Fertility Clinics
3.1.2 Hospitals
3.1.3 Surgical Centers
3.1.4 Research Laboratories
3.2 Global IVF-Procedure Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global IVF-Procedure Historic Market Size by Application (2018-2023)
3.2.2 Global IVF-Procedure Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America IVF-Procedure Revenue Breakdown by Application (2018-2029)
3.3.2 Europe IVF-Procedure Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific IVF-Procedure Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America IVF-Procedure Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa IVF-Procedure Revenue Breakdown by Application (2018-2029)
4 IVF-Procedure Competition Analysis by Players
4.1 Global IVF-Procedure Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in IVF-Procedure as of 2022)
4.3 Date of Key Players Enter into IVF-Procedure Market
4.4 Global Top Players IVF-Procedure Headquarters and Area Served
4.5 Key Players IVF-Procedure Product Solution and Service
4.6 Competitive Status
4.6.1 IVF-Procedure Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 OvaScience
5.1.1 OvaScience Profile
5.1.2 OvaScience Main Business
5.1.3 OvaScience IVF-Procedure Products, Services and Solutions
5.1.4 OvaScience IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.1.5 OvaScience Recent Developments
5.2 EMD Serono
5.2.1 EMD Serono Profile
5.2.2 EMD Serono Main Business
5.2.3 EMD Serono IVF-Procedure Products, Services and Solutions
5.2.4 EMD Serono IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.2.5 EMD Serono Recent Developments
5.3 Vitrolife
5.3.1 Vitrolife Profile
5.3.2 Vitrolife Main Business
5.3.3 Vitrolife IVF-Procedure Products, Services and Solutions
5.3.4 Vitrolife IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.3.5 Irvine Scientific Recent Developments
5.4 Irvine Scientific
5.4.1 Irvine Scientific Profile
5.4.2 Irvine Scientific Main Business
5.4.3 Irvine Scientific IVF-Procedure Products, Services and Solutions
5.4.4 Irvine Scientific IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.4.5 Irvine Scientific Recent Developments
5.5 Cook Medical Inc
5.5.1 Cook Medical Inc Profile
5.5.2 Cook Medical Inc Main Business
5.5.3 Cook Medical Inc IVF-Procedure Products, Services and Solutions
5.5.4 Cook Medical Inc IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.5.5 Cook Medical Inc Recent Developments
5.6 Cooper Surgical Inc
5.6.1 Cooper Surgical Inc Profile
5.6.2 Cooper Surgical Inc Main Business
5.6.3 Cooper Surgical Inc IVF-Procedure Products, Services and Solutions
5.6.4 Cooper Surgical Inc IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.6.5 Cooper Surgical Inc Recent Developments
5.7 Genea Biomedx
5.7.1 Genea Biomedx Profile
5.7.2 Genea Biomedx Main Business
5.7.3 Genea Biomedx IVF-Procedure Products, Services and Solutions
5.7.4 Genea Biomedx IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.7.5 Genea Biomedx Recent Developments
5.8 Thermo Fisher Scientific
5.8.1 Thermo Fisher Scientific Profile
5.8.2 Thermo Fisher Scientific Main Business
5.8.3 Thermo Fisher Scientific IVF-Procedure Products, Services and Solutions
5.8.4 Thermo Fisher Scientific IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.8.5 Thermo Fisher Scientific Recent Developments
5.9 Progyny
5.9.1 Progyny Profile
5.9.2 Progyny Main Business
5.9.3 Progyny IVF-Procedure Products, Services and Solutions
5.9.4 Progyny IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.9.5 Progyny Recent Developments
5.10 Boston IVF
5.10.1 Boston IVF Profile
5.10.2 Boston IVF Main Business
5.10.3 Boston IVF IVF-Procedure Products, Services and Solutions
5.10.4 Boston IVF IVF-Procedure Revenue (US$ Million) & (2018-2023)
5.10.5 Boston IVF Recent Developments
6 North America
6.1 North America IVF-Procedure Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe IVF-Procedure Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific IVF-Procedure Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America IVF-Procedure Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa IVF-Procedure Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 IVF-Procedure Market Dynamics
11.1 IVF-Procedure Industry Trends
11.2 IVF-Procedure Market Drivers
11.3 IVF-Procedure Market Challenges
11.4 IVF-Procedure Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’